11 results match your criteria: "Institute for Precision Cardiovascular Medicine[Affiliation]"
JACC Heart Fail
March 2024
Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address:
Background: Individuals with acute decompensated heart failure (ADHF) have a varying response to diuretic therapy. Strategies for the early identification of low diuretic efficiency to inform decongestion therapies are lacking.
Objectives: The authors sought to develop and externally validate a machine learning-based phenomapping approach and integer-based diuresis score to identify patients with low diuretic efficiency.
Circulation
January 2022
Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (S.R., A.P.).
Background: Socioeconomic disadvantage is a strong determinant of adverse outcomes in patients with heart failure. However, the contribution of community-level economic distress to adverse outcomes in heart failure may differ across races and ethnicities.
Methods: Patients of self-reported Black, White, and Hispanic race and ethnicity hospitalized with heart failure between 2014 and 2019 were identified from the Medicare MedPAR Part A 100% Files.
JAMA Cardiol
September 2021
CVPath Institute, Gaithersburg, Maryland.
Appl Sci (Basel)
May 2020
Electrical Engineering and Computer Science, Chapman University, Orange, CA 92866, USA.
Accessible interactive tools that integrate machine learning methods with clinical research and reduce the programming experience required are needed to move science forward. Here, we present Machine Learning for Medical Exploration and Data-Inspired Care (ML-MEDIC), a point-and-click, interactive tool with a visual interface for facilitating machine learning and statistical analyses in clinical research. We deployed ML-MEDIC in the American Heart Association (AHA) Precision Medicine Platform to provide secure internet access and facilitate collaboration.
View Article and Find Full Text PDFCirc Heart Fail
February 2021
Divisions of Cardiology and Bioinformatics and Personalized Medicine, Department of Medicine, (D.P.K.), University of Colorado Anschutz Medical School, Aurora.
Background: Coronary heart disease, heart failure (HF), and stroke are complex diseases with multiple phenotypes. While many risk factors for these diseases are well known, investigation of as-yet unidentified risk factors may improve risk assessment and patient adherence to prevention guidelines. We investigated the diet domain in FHS (Framingham Heart Study), CHS (Cardiovascular Heart Study), and the ARIC study (Atherosclerosis Risk in Communities) to identify potential lifestyle and behavioral factors associated with coronary heart disease, HF, and stroke.
View Article and Find Full Text PDFCirc Cardiovasc Qual Outcomes
October 2020
Division of Cardiology, University of Colorado School of Medicine, Aurora, CO (L.M.S., D.P.K.).
Use of machine learning (ML) in clinical research is growing steadily given the increasing availability of complex clinical data sets. ML presents important advantages in terms of predictive performance and identifying undiscovered subpopulations of patients with specific physiology and prognoses. Despite this popularity, many clinicians and researchers are not yet familiar with evaluating and interpreting ML analyses.
View Article and Find Full Text PDFProg Cardiovasc Dis
March 2019
Institute for Precision Cardiovascular Medicine, American Heart Association, Dallas, TX, United States of America; Department of Medicine, University of Minnesota, Minneapolis, MN, United States of America; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.
This paper focuses on the significant role of government in promoting precision medicine and public health and the potential intersection with healthy living (HL) and population health. Recent research has highlighted the interplay between genes, environments and different exposures individuals and populations experience over a lifetime. These interactions between longitudinal behaviors, epigenetics, and expression of the human genome have the potential to transform health and well-being, even within a single generation.
View Article and Find Full Text PDFJCI Insight
June 2018
Department of Medicine, University of Washington Medicine Diabetes Institute, University of Washington School of Medicine, Seattle, Washington, USA.
Metabolic syndrome contributes to cardiovascular disease partly through systemic risk factors. However, local processes in the artery wall are becoming increasingly recognized to exacerbate atherosclerosis both in mice and humans. We show that arterial smooth muscle cell (SMC) glucose metabolism markedly synergizes with metabolic syndrome in accelerating atherosclerosis progression, using a low-density lipoprotein receptor-deficient mouse model.
View Article and Find Full Text PDFCirculation
February 2018
Institute for Precision Cardiovascular Medicine, American Heart Association, Dallas, TX (T.A.K.-H., L.M.S., J.L.H.)
Integrating the open science movement with impactful discoveries in science, velocity of technology, and raw power of cloud computing has led to an unprecedented opportunity for scientific discovery. The American Heart Association recently established the Precision Medicine Platform through the efforts of multiple American Heart Association volunteers and a collaboration with Amazon Web Services. The cloud-based platform, powered by Amazon Web Services and available at https://precision.
View Article and Find Full Text PDFStroke
February 2018
From the Center for Genomic Medicine (K.C., C.G.-F., C.K., S.M., N.V., J.R.), Division of Neurocritical Care and Emergency Neurology, Department of Neurology (J.R.), and J. Philip Kistler Stroke Research Center (J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA (K.C., C.G.-F., C.K., S.M., J.F., N.B., M.v.G., B.A., M.C., N.V., J.R., G.J.F.); Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, New Haven, CT (L.M., G.J.F.); Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilian University, Munich, Germany (R.M.); Institute for Precision Cardiovascular Medicine, American Heart Association National Center, Dallas, TX (J.L.H.); Department of Medicine, Lillehei Heart Institute, University of Minnesota, Minneapolis (J.L.H.); and McMaster University, Hamilton, Ontario, Canada (M.C.).
Circulation
April 2017
From American Heart Association, National Center, Institute for Precision Cardiovascular Medicine, Dallas, TX; and Lillehei Heart Institute, Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis.